Lima, K., Pereira-Martins, D. A., de Miranda, L. B. L., Coelho-Silva, J. L., Leandro, G. d. S., Weinhäuser, I., . . . Machado-Neto, J. A. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12(11), . https://doi.org/10.1038/s41408-022-00747-w
Chicago-referens (17:e uppl.)Lima, Keli, et al. "The PIP4K2 Inhibitor THZ-P1-2 Exhibits Antileukemia Activity by Disruption of Mitochondrial Homeostasis and Autophagy." Blood Cancer Journal 12, no. 11 (2022). https://doi.org/10.1038/s41408-022-00747-w.
MLA-referens (9:e uppl.)Lima, Keli, et al. "The PIP4K2 Inhibitor THZ-P1-2 Exhibits Antileukemia Activity by Disruption of Mitochondrial Homeostasis and Autophagy." Blood Cancer Journal, vol. 12, no. 11, 2022, https://doi.org/10.1038/s41408-022-00747-w.
